Skip to main content
    E

    Evolus Inc (EOLS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $6.63
    -0.33 (-4.74%)

    Market Cap: $460.67M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Evolus Inc (EOLS) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Evolus are Evotec SE ADR (EVO), Lifecore Biomedical (LFCR) and Emergent Biosolutions (EBS). By market cap, Evolus ranks 8th of the 13 companies on this page; Harrow Health (HROW) is the largest at $1.13B. The median P/E of the 3 companies with a P/E is 5.4x.

    Peer Comparison

    EOLS's ROIC of -12.7% is below the peer median of -4.9%, and its revenue growth of 13.0% is above the median of 8.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Evolus (EOLS)$460.67MN/A1.3x-9.6%-12.7%13.0%0.00%
    Evotec SE ADR (EVO)$561.51MN/A0.7x-25.2%-15.1%0.6%0.00%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    Emergent Biosolutions Inc (EBS)$297.69MN/A0.5x-40.2%-20.5%-52.4%0.00%
    Collegium Pharmaceutical Inc (COLL)$786.83M3.7x1.0x4.7%8.1%3.3%0.00%
    Kamada (KMDA)$467.05M18.9x2.4x12.7%N/A10.7%2.10%
    Tilray Inc (TLRY)$359.12MN/A0.3x-17.1%-4.9%22.7%0.00%
    Alpha Teknova Inc (TKNO)$516.43MN/A9.1x-34.8%-20.5%21.5%0.00%
    BioAge Labs, Inc (BIOA)$255.03MN/A27.9x0.0%N/A-85.5%0.00%
    Harrow Health Inc (HROW)$1.13BN/A3.6x-9.4%-0.3%38.6%0.00%
    Ironwood Pharmaceuticals Inc (IRWD)$799.61M5.4x2.0x37.4%70.5%9.0%0.00%
    Evolent Health Inc (EVH)$554.22MN/A0.2x-21.7%-32.4%51.3%0.00%
    Journey Medical Corp (DERM)$122.24MN/A1.5x-7.3%-2.8%7.6%0.00%
    Peer median$491.74M5.4x1.5x-13.2%-4.9%8.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Evolus, ranked by how closely their business, size, sector and industry match. The largest group, 11 of the 12, is in Drug Manufacturers - Specialty & Generic; the other one is in Health Information Services.

    CompanyAboutPeers
    Evotec SE ADR (EVO)Drug Manufacturers - Specialty & Generic
    Evotec SE is a prominent global biotechnology company headquartered in Hamburg, Germany...
    EVO competitors
    Lifecore Biomedical Inc. (LFCR)Drug Manufacturers - Specialty & Generic
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    Emergent Biosolutions Inc (EBS)Drug Manufacturers - Specialty & Generic
    Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations...
    EBS competitors
    Collegium Pharmaceutical Inc (COLL)Drug Manufacturers - Specialty & Generic
    Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and markets pain management medications.
    COLL competitors
    Kamada (KMDA)Drug Manufacturers - Specialty & Generic
    Kamada Ltd. develops, produces and markets plasma-derived protein therapies for orphan indications. The company is headquartered in Rehovot, Israel.
    KMDA competitors
    Tilray Inc (TLRY)Drug Manufacturers - Specialty & Generic
    Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids.
    TLRY competitors
    Alpha Teknova Inc (TKNO)Drug Manufacturers - Specialty & Generic
    Alpha Teknova Inc (TKNO) is a leading entity in the synthetic biology industry, specializing in the development of essential biological reagents and supplements...
    TKNO competitors
    BioAge Labs, Inc (BIOA)Drug Manufacturers - Specialty & Generic
    BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United...
    BIOA competitors
    Harrow Health Inc (HROW)Drug Manufacturers - Specialty & Generic
    Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
    HROW competitors
    Ironwood Pharmaceuticals Inc (IRWD)Drug Manufacturers - Specialty & Generic
    Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products.
    IRWD competitors
    Evolent Health Inc (EVH)Health Information Services
    Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States.
    EVH competitors
    Journey Medical Corp (DERM)Drug Manufacturers - Specialty & Generic
    Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
    DERM competitors

    Frequently Asked Questions About EOLS

    Who are Evolus' main competitors?

    The companies most similar to Evolus include Evotec SE ADR (EVO), Lifecore Biomedical (LFCR), Emergent Biosolutions (EBS), Collegium Pharmaceutical (COLL) and Kamada (KMDA), listed from the closest match.

    Who is Evolus' biggest competitor?

    Harrow Health (HROW) is the largest of the similar companies at $1.13B; Evotec SE ADR (EVO) is the closest match by business profile, size, sector and industry.

    How does EOLS stock compare with its competitors?

    EOLS' P/S is 1.3x against a peer median of 1.5x; its net margin is -9.6% against a peer median of -13.2%.

    Which of Evolus' competitors pays a higher dividend?

    Evolus pays no dividend. Kamada (KMDA) has a higher forward dividend yield; Kamada (KMDA) has the highest at 2.10%.

    Is Evolus bigger than its competitors?

    No. Evolus is 8th by market cap among the 13 companies on this page; the largest is Harrow Health (HROW) at $1.13B.